SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001593968-23-001250
Filing Date
2023-08-23
Accepted
2023-08-23 17:17:42
Documents
2
Period of Report
2023-08-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 3  
1 PRIMARY DOCUMENT primary_01.xml 3 7516
2 EX-24 DOCUMENT poa.txt EX-24 3463
  Complete submission text file 0001593968-23-001250.txt   12528
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Issuer) CIK: 0001824893 (see all company filings)

IRS No.: 981556622 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SURROZEN, INC. 171 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Li Yang (Reporting) CIK: 0001990537 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39635 | Film No.: 231198357